IGC

IGC Pharma, Inc.

Insider trading activity for IGC Pharma, Inc., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 6 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 12 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Transaction history

The 36 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Jun 30	Mukunda Ram	CEO	AGRANT	2.2M	$0.27	$601.1K	+47.9%	Open the original filing on SEC.gov
Jun 30	Grimaldi Claudia	PFO	AGRANT	2M	$0.27	$553.1K	+149.2%	Open the original filing on SEC.gov
Apr 1	Prins Richard K	Director	MEXER◆	70,000	—	—	—	Open the original filing on SEC.gov
Apr 1	Prins Richard K	Director	MEXER◆	100,000	—	—	—	Open the original filing on SEC.gov
Apr 1	Prins Richard K	Director	MEXER	70,000	—	—	+4.8%	Open the original filing on SEC.gov
Apr 1	Prins Richard K	Director	MEXER	100,000	—	—	+7.3%	Open the original filing on SEC.gov
Apr 1	Mukunda Ram	CEO	MEXER◆	33,332	—	—	—	Open the original filing on SEC.gov
Apr 1	Mukunda Ram	CEO	MEXER◆	16,667	—	—	—	Open the original filing on SEC.gov
Apr 1	Mukunda Ram	CEO	MEXER◆	323,077	—	—	—	Open the original filing on SEC.gov
Apr 1	Mukunda Ram	CEO	MEXER◆	333,333	—	—	—	Open the original filing on SEC.gov
Apr 1	Mukunda Ram	CEO	MEXER	33,332	—	—	+3.8%	Open the original filing on SEC.gov
Apr 1	Mukunda Ram	CEO	MEXER	16,667	—	—	+1.9%	Open the original filing on SEC.gov
Apr 1	Mukunda Ram	CEO	MEXER	323,077	$0.26	$84K	+7.5%	Open the original filing on SEC.gov
Apr 1	Mukunda Ram	CEO	MEXER	333,333	—	—	+8.3%	Open the original filing on SEC.gov
Apr 1	Moran James P	Director	MEXER◆	50,000	—	—	—	Open the original filing on SEC.gov
Apr 1	Moran James P	Director	MEXER◆	80,000	—	—	—	Open the original filing on SEC.gov
Apr 1	Moran James P	Director	MEXER	50,000	—	—	+4.2%	Open the original filing on SEC.gov
Apr 1	Moran James P	Director	MEXER	80,000	—	—	+7.2%	Open the original filing on SEC.gov
Apr 1	Grimaldi Claudia	PFO	MEXER◆	138,462	—	—	—	Open the original filing on SEC.gov
Apr 1	Grimaldi Claudia	PFO	MEXER◆	100,000	—	—	—	Open the original filing on SEC.gov
Apr 1	Grimaldi Claudia	PFO	MEXER	138,462	$0.26	$36K	+11.2%	Open the original filing on SEC.gov
Apr 1	Grimaldi Claudia	PFO	MEXER	100,000	—	—	+8.8%	Open the original filing on SEC.gov
Feb 3	Mukunda Ram	CEO	AGRANT◆	66,666	—	—	—	Open the original filing on SEC.gov
Feb 3	Mukunda Ram	CEO	AGRANT◆	16,667	—	—	—	Open the original filing on SEC.gov
Feb 3	Mukunda Ram	CEO	MEXER	50,000	—	—	+6.2%	Open the original filing on SEC.gov
Jan 19	Prins Richard K	Director	MEXER◆	100,000	—	—	—	Open the original filing on SEC.gov
Jan 19	Prins Richard K	Director	MEXER	100,000	—	—	+7.9%	Open the original filing on SEC.gov
Oct 17, 2025	Mukunda Ram	CEO	AGRANT◆	1.5M	—	—	—	Open the original filing on SEC.gov
Oct 17, 2025	Mukunda Ram	CEO	AGRANT◆	3M	—	—	—	Open the original filing on SEC.gov
Oct 17, 2025	Mukunda Ram	CEO	GGIFT	100,000	—	—	-2.4%	Open the original filing on SEC.gov
Oct 17, 2025	Moran James P	Director	AGRANT◆	500,000	—	—	—	Open the original filing on SEC.gov
Oct 17, 2025	Lierman Terry L	Director	AGRANT◆	500,000	—	—	—	Open the original filing on SEC.gov
Oct 17, 2025	Grimaldi Claudia	PFO	AGRANT◆	500,000	—	—	—	Open the original filing on SEC.gov
Oct 17, 2025	Grimaldi Claudia	PFO	AGRANT◆	1M	—	—	—	Open the original filing on SEC.gov
Oct 17, 2025	Grimaldi Claudia	PFO	GGIFT	50,000	—	—	-4.2%	Open the original filing on SEC.gov
Oct 17, 2025	Prins Richard K	Director	AGRANT◆	750,000	—	—	—	Open the original filing on SEC.gov

AGRANT$601.1K

Mukunda Ram · CEOJun 30

2.2M sh @ $0.27 · +47.9% own

AGRANT$553.1K

Grimaldi Claudia · PFOJun 30

2M sh @ $0.27 · +149.2% own

MEXER◆—

Prins Richard K · DirectorApr 1

70,000 sh

MEXER◆—

Prins Richard K · DirectorApr 1

100,000 sh

MEXER—

Prins Richard K · DirectorApr 1

70,000 sh · +4.8% own

MEXER—

Prins Richard K · DirectorApr 1

100,000 sh · +7.3% own

MEXER◆—

Mukunda Ram · CEOApr 1

33,332 sh

MEXER◆—

Mukunda Ram · CEOApr 1

16,667 sh

MEXER◆—

Mukunda Ram · CEOApr 1

323,077 sh

MEXER◆—

Mukunda Ram · CEOApr 1

333,333 sh

MEXER—

Mukunda Ram · CEOApr 1

33,332 sh · +3.8% own

MEXER—

Mukunda Ram · CEOApr 1

16,667 sh · +1.9% own

MEXER$84K

Mukunda Ram · CEOApr 1

323,077 sh @ $0.26 · +7.5% own

MEXER—

Mukunda Ram · CEOApr 1

333,333 sh · +8.3% own

MEXER◆—

Moran James P · DirectorApr 1

50,000 sh

MEXER◆—

Moran James P · DirectorApr 1

80,000 sh

MEXER—

Moran James P · DirectorApr 1

50,000 sh · +4.2% own

MEXER—

Moran James P · DirectorApr 1

80,000 sh · +7.2% own

MEXER◆—

Grimaldi Claudia · PFOApr 1

138,462 sh

MEXER◆—

Grimaldi Claudia · PFOApr 1

100,000 sh

MEXER$36K

Grimaldi Claudia · PFOApr 1

138,462 sh @ $0.26 · +11.2% own

MEXER—

Grimaldi Claudia · PFOApr 1

100,000 sh · +8.8% own

AGRANT◆—

Mukunda Ram · CEOFeb 3

66,666 sh

AGRANT◆—

Mukunda Ram · CEOFeb 3

16,667 sh

MEXER—

Mukunda Ram · CEOFeb 3

50,000 sh · +6.2% own

MEXER◆—

Prins Richard K · DirectorJan 19

100,000 sh

MEXER—

Prins Richard K · DirectorJan 19

100,000 sh · +7.9% own

AGRANT◆—

Mukunda Ram · CEOOct 17, 2025

1.5M sh

AGRANT◆—

Mukunda Ram · CEOOct 17, 2025

3M sh

GGIFT—

Mukunda Ram · CEOOct 17, 2025

100,000 sh · -2.4% own

AGRANT◆—

Moran James P · DirectorOct 17, 2025

500,000 sh

AGRANT◆—

Lierman Terry L · DirectorOct 17, 2025

500,000 sh

AGRANT◆—

Grimaldi Claudia · PFOOct 17, 2025

500,000 sh

AGRANT◆—

Grimaldi Claudia · PFOOct 17, 2025

1M sh

GGIFT—

Grimaldi Claudia · PFOOct 17, 2025

50,000 sh · -4.2% own

AGRANT◆—

Prins Richard K · DirectorOct 17, 2025

750,000 sh

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

All 13 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More biotech & pharma companies

Other issuers in the same industry with insider filings on record.

Whole sector →